Posts

Humanetix joins forces with Provider Assist to drive end-to-end people, business, and digital solutions.

/in , ,

Humanetix joins forces with Provider Assist to drive end-to-end people, business, and digital solutions. BioScience Managers is proud to share that portfolio company Humanetix (HX) has entered a strategic acquisition Provider Assist (PA), a leading healthcare solutions provider in Australia. This milestone represents a robust validation of Humanetix’s technology and its impact in aged […]

Read more

Adherium announces interim results from the iCare respiratory care program

/in ,

Adherium announces interim results from the iCare respiratory care program Adherium has today announced interim results from the iCARE respiratory care program, demonstrating positive clinical outcomes, including breakthrough adherence and patient engagement, whilst using Adherium’s Hailie® Smartinhaler technology. The iCARE program, conducted in partnership with Intermountain Health and CareCentra, is one of the largest real-world […]

Read more

Adherium Conversation Series: Transforming COPD care through remote monitoring

/in ,

Adherium Conversation Series: Transforming COPD care through remote monitoring With 46 years of respiratory therapy experience, Kimberly Bennion, MsHS, RRT, CHC, FAARC, is leading the Intermountain COPD and Adult Asthma Remote Evaluation Study, a groundbreaking USD $5M research initiative focused on improving care for vulnerable pulmonary patients. Using Adherium’s Hailie® Smartinhaler® technology, Kimberly’s team is […]

Read more

Adherium conducts A$0.35m placement to institutional investor

/in ,

Adherium conducts A$0.35m placement to institutional investor Summary: Firm commitments received for A$0.35M institutional placement (before costs) at A$0.005 per share The proceeds, together with existing cash reserves and proceeds from the recent ANREO will allow Adherium toexecute on its growth plan and provide balance sheet strength. Melbourne, Australia – 4 August 2025: is pleased to announce that it has received firm commitments from sophisticated and professional investors to raise approximately A$0.35M (before costs) through an institutional placement (the “Placement”). The Placement was undertaken on the same terms as the recent partially underwritten […]

Read more

New Study: Arthroplasty in Medicare: A cost distribution analysis of Medicare beneficiaries undergoing total knee arthroplasty

/in

New Study: Arthroplasty in Medicare: A cost distribution analysis of Medicare beneficiaries undergoing total knee arthroplasty A recent study of 400,000+ Medicare patients who underwent Total Knee Arthroplasty (TKA) reveals a striking insight: Just 30% of patients (the high-cost group) account for 78% of Medicare spending in the first year post-surgery. Key findings: – TKA-related complications (like infection or implant […]

Read more

Adherium appoints Dawn Bitz as Chief Executive Officer

/in ,

Adherium appoints Dawn Bitz as Chief Executive Officer Melbourne, Australia – 22 July 2025: Leading digital health company Adherium Limited (ASX:ADR), has today announced the appointment of Dawn Bitz as Chief Executive Officer (CEO), effective immediately. Ms. Bitz, based in the United States, brings nearly three decades of transformational leadership experience in the global medical […]

Read more

Conversation Series: Dr William A. McCann, MD | Transforming asthma care at scale

/in ,

Conversation Series: Dr William A. McCann, MD | Transforming asthma care at scale Dr. William McCann, Chief Medical Officer of Allergy Partners PLLC, the largest allergy and asthma practice in the U.S. with 150 board-certified allergists across 20 states, shares how Allergy Partners is leveraging Hailie® Smartinhaler® technology to combat medication non-adherence in asthma patients, […]

Read more